Director, Office of Clinical Pharmacology
U.S. Food and Drug Administration
Issam Zineh is Director of the Office of Clinical Pharmacology (OCP) at the U.S Food and Drug Administration (FDA). He has held various leadership positions at FDA including Associate Director for Genomics in OCP and Co-Director of the CDER Biomarker Qualification Program, and serves on the CDER Medical Policy Council, Advancing Rare Disease Cures Steering Committee, and other governance groups. Dr. Zineh received his PharmD from Northeastern University and completed his residency at Duke University Medical Center. He completed a fellowship in cardiovascular pharmacogenomics at the University of Florida (UF) where he also obtained his MPH in Health Policy and Management. As Director of OCP, Dr. Zineh leads a staff of over 260 regulatory, research, program/project management, and administrative staff in FDA’s efforts to enhance drug development and promote regulatory innovation through clinical pharmacology and experimental medicine.
Disclosure information not submitted.
Friday, March 29, 2024
10:30 AM – 11:00 AM MDT